SCHEMBL2069575

SCHEMBL2069575

Cc1nc(-c2ccc(Cl)cc2)sc1C(=O)CC1CCCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
ALDH1A1 P00352 1/20 0.48
MAPT P10636 1/20 0.48
KMT2A Q03164 1/20 0.48
PPARA Q07869 9/20 0.48
GLS O94925 2/20 0.47
CHRM4 P08173 1/20 0.46
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 1/20 0.44
POLB P06746 1/20 0.44
FNTA P49354 1/20 0.44
FNTB P49356 1/20 0.44
ACKR3 P25106 1/20 0.44
PPARG P37231 1/20 0.44
PPARD Q03181 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2070349 0.87 PPARA (0.61) PPARACHRM4SMN1; SMN2ACKR3PPARG
SCHEMBL12844874 0.87 MAPT (0.48) MEN1ALDH1A1MAPTKMT2APPARA
SCHEMBL2069923 0.85 PPARA (0.61) PPARACHRM4RAB9ASMN1; SMN2KDM4E
SCHEMBL2069079 0.83 PPARA (0.48) MEN1KMT2APPARAGLSCHRM4
SCHEMBL2069528 0.82 PPARA (0.63) PPARACHRM4SMN1; SMN2PPARGPPARD
SCHEMBL2069365 0.82 PPARA (0.63) PPARACHRM4SMN1; SMN2PPARGPPARD
SCHEMBL2069366 0.82 PPARA (0.63) PPARACHRM4SMN1; SMN2PPARGPPARD
SCHEMBL2069312 0.82 PPARA (0.60) PPARACHRM4RAB9ASMN1; SMN2KDM4E
SCHEMBL2069948 0.79 PPARA (0.61) MEN1KMT2APPARARAB9AACKR3
SCHEMBL2069970 0.79 PPARA (0.61) MEN1KMT2APPARARAB9AACKR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-7902367-B2 Cyclic amino benzoic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-10-25 US disclosed
EP-1780210-A1 NOVEL CYCLIC AMINOBENZOIC ACID DERIVATIVE Kyorin Pharmaceutical Co., Ltd. (JP) 2007-05-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249580-A1 Novel Cyclic Amino Benzoic Acid Derivative PPARA, PPARG, PPARD MEN1 3887/4885ALDH1A1 616/4885MAPT 4544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.